Tradestie Institutional Equity Comparison Engine
MBIO vs NCNA โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
MBIO Overall Edge
MBIO Captures Institutional Edge (2โ0 Pillars ยท 2โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Mustang Bio, Inc. (MBIO) driven by superior Growth & Margin, Momentum & Technical. Fundamentally, MBIO trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus NCNA at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, MBIO sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against NCNA sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
MBIO N/M vs NCNA N/M Fwd P/E
Growth & Margin Winner
MBIO
Op Margin 0.0% vs 0.0% ยท YoY +0.0% vs +0.0%
Momentum & Technical Winner
MBIO
1Y -67.8% vs -72.4% ยท 52W Pos 4% vs 2%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
MBIO
NASDAQ
Mustang Bio, Inc.
Pharmaceutical Preparations
$0.39
-0.58% 1D
Market Cap
$3.2M
1M Return
+5.2%
1Y Return
-67.84%
Forward P/E
N/M
Unified AI Score
42.9 / 100
HOLD
Tech 40.0
Fund 49.0
Flow 50.0
Mom 70.0
NCNA
NASDAQ
NuCana plc American Depositary Share
Pharmaceutical Preparations
$0.94
+8.93% 1D
Market Cap
$3.9M
1M Return
-3.79%
1Y Return
-72.43%
Forward P/E
N/M
Unified AI Score
43.2 / 100
HOLD
Tech 27.0
Fund 46.0
Flow 50.0
Mom 68.9
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
MBIO -67.84%
NCNA -72.43%
Spread: +4.59 pp (MBIO Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
MBIO TTM Op. Margin: 0.0%
NCNA TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on MBIO vs NCNA. Trailing 12-month operating profitability (MBIO 0.0% vs NCNA 0.0%) and valuation multiples (MBIO N/M vs NCNA N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | MBIO | NCNA | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $3.2M | $3.9M | Larger Scale | Tie |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +0.0% | +0.0% | Higher Growth | Tie |
| Operating Margin (TTM) Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -43.1% | -70.3% | Higher ROE | MBIO |
| 52-Week Range Position Momentum | 4% ($0โ$1) | 2% ($1โ$5) | Stronger Trend | MBIO |
| Beta / 30D Volatility Risk Regime | 0.68ฮฒ ยท 85% Vol | 1.49ฮฒ ยท 59% Vol | Lower Realized Risk | NCNA |
| Unified Institutional Score Composite Signal | 42.9 / 100 (HOLD) | 43.2 / 100 (HOLD) | Higher Composite | NCNA |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full MBIO vs NCNA Buy Guide
MBIO
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
NCNA
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither MBIO nor NCNA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.